BioVie Inc (BIVI)
0.4904
-0.01
(-1.90%)
USD |
NASDAQ |
May 03, 16:00
0.49
0.00 (0.00%)
After-Hours: 20:00
BioVie Cash from Operations (TTM): -41.11M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -41.11M |
September 30, 2023 | -43.21M |
June 30, 2023 | -40.25M |
March 31, 2023 | -34.83M |
December 31, 2022 | -28.98M |
September 30, 2022 | -25.68M |
June 30, 2022 | -18.99M |
March 31, 2022 | -20.13M |
December 31, 2021 | -15.29M |
September 30, 2021 | -11.90M |
June 30, 2021 | -10.45M |
March 31, 2021 | -3.805M |
December 31, 2020 | -3.165M |
September 30, 2020 | -2.121M |
June 30, 2020 | -1.628M |
March 31, 2020 | -1.900M |
December 31, 2019 | -2.157M |
September 30, 2019 | -2.651M |
June 30, 2019 | -2.502M |
March 31, 2019 | -2.079M |
Date | Value |
---|---|
December 31, 2018 | -1.469M |
September 30, 2018 | -0.8598M |
June 30, 2018 | -0.6213M |
March 31, 2018 | -0.5372M |
December 31, 2017 | -0.7572M |
September 30, 2017 | -0.699M |
June 30, 2017 | -0.6236M |
March 31, 2017 | -0.6178M |
December 31, 2016 | -0.3654M |
September 30, 2016 | -0.2797M |
June 30, 2016 | -0.1536M |
March 31, 2016 | -0.0453M |
December 31, 2015 | -0.0385M |
September 30, 2015 | -0.0526M |
June 30, 2015 | -0.0654M |
March 31, 2015 | -0.0667M |
December 31, 2014 | -0.1188M |
September 30, 2014 | -0.1277M |
June 30, 2014 | -0.1728M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-43.21M
Minimum
Sep 2023
-1.628M
Maximum
Jun 2020
-16.36M
Average
-11.90M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Adial Pharmaceuticals Inc | -6.807M |
Precision BioSciences Inc | -84.11M |
Cardiff Oncology Inc | -30.89M |
Jaguar Health Inc | -33.24M |
First Wave BioPharma Inc | -12.38M |